TABLE 3.

Antagonists

	HS activation	HS TQS	LS activation	LS TQS
3a. Responses	Average ± S.D.	Average ± S.D.	Average ± S.D.	Average ± S.D.
MLA	0.007 ± 0.003	0.016 ± 0.009#	0.003 ± 0.003	0.003 ± 0.003
DHβE	0.046 ± 0.032#	0.085 ± 0.046#	0.004 ± 0.002	0.004 ± 0.002
3b. Corrected P values
	Drug versus Drug plus TQS		Drug plus TQS versus TQS alone
	P value HS	P value LS	P value HS	P value LS
MLA	0.0492	0.1879	0.0053#	1.4235
DHβE	0.0201	2.0367	0.0209#	0.8528

#P < 0.05, drugs co-applied with TQS reduced response compared with TQS alone.